Company overview
Biosynth supplies critical raw materials and contract manufacturing services for life sciences and diagnostics, specializing in carbohydrates, nucleosides, peptides, and enzyme substrates. The company offers custom synthesis, research products, and drug discovery support to secure supply chains. Their expertise includes bioconjugate manufacturing and custom peptide libraries for screening and characterization.
Biosynth is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include biosynth, custom peptides, raw materials pharma, life sciences reagents, contract manufacturing.
Industry categories: Life Science Reagents, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.biosynth.com
- Categories
- Life Science Reagents, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- biosynth, custom peptides, raw materials pharma, life sciences reagents, contract manufacturing
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What products and services does Biosynth offer for pharmaceutical R&D?
- Biosynth provides life sciences reagents, custom synthesis, manufacturing services, carbohydrates, nucleosides, peptides, enzyme substrates, and natural products, along with drug discovery and bioconjugate development.
- Does Biosynth support custom peptide manufacturing?
- Yes, Biosynth offers custom peptides, micro-scale libraries for screening, epitope mapping, protein characterization, and a peptide quote tool for quick customization.
- What industries does Biosynth serve?
- Biosynth secures supply chains for life sciences, diagnostics, and pharmaceuticals, with services from discovery to clinical supply including complex chemistry synthesis and manufacturing.
Related editorial coverage
- CPhI Americas 2026: Pharma Manufacturing Trends in Philadelphia
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
